BIM-018 is a synthetic cannabinoid that is the benzimidazole analog of JWH-018. It is presumed to be a potent agonist of the CB<sub>2</sub> receptor and has been sold online as a designer drug.
Related benzimidazole derivatives have been reported to be highly selective agonists for the CB<sub>2</sub> receptor.